Tablets 25mg, 50mg

 Inflammatory bowel disease, Rheumatic diseases, Dermatology.

 Myasthenia Gravis.

Primary care prescribers are advised not to take on prescribing of these medicines unless they have been adequately informed by letter of their responsibilities with regards monitoring, side effects and interactions and are happy to take on the prescribing responsibility. A copy of locally approved shared care guidelines should accompany this letter which outlines these responsibilities. Primary care prescribers should then tell secondary care of their intentions as soon as possible by letter so that arrangements can be made for the transfer of care.

 Transplant rejection.

See section 01.05.03 and 13.05.03.

Capsules 250mg

Tablets 500mg
Oral suspension 1g/5mL

 Cellcept^® for transplant patients only.
 Generic prescribing for dermatology use.

 Complex pain syndrome.